-
GENSURE 2019-NCOV ANTIGEN RAPID TEST (LATERAL FLOW) IS AN IMMUNOCHROMATOGRAPHIC ASSAY FOR THE RAPID IDENTIFICATION OF THE NEW CORONAVIRUS (2019-NCOV) ARISING FROM ANTIGENS EXTRACTED FROM SAMPLES TAKEN VIA NASAL AND NOSOPHARYNGAL SWABS.
-
DETECTION TIME 10/15 MINUTES.
-
THE TEST IS EASY TO PERFORM AND REQUIRES A FEW STEPS TO PERFORM.
-
NO CONTAINMENT OR PREVENTION MEASURES SUCH AS BIOHAZARD HOODS ARE NECESSARY.
-
IT IS POSSIBLE TO ANALYZE SAMPLES STORED IN VIRAL TRANSPORT MEDIA WITH OR WITHOUT ACTIVATOR.
-
FOR PROFESSIONAL USE ONLY
-
NASAL OR NOSOPHARYNGAL SWABS ARE PACKAGED INDIVIDUALLY
-
LATEX FREE, PHTHALATE FREE, APYROGEN.
-
FREE FROM PCR INHIBITORS FOR THE RESEARCH OF SARS COV2
-
BELONG TO THE WANTED PATHOGENS
-
SENSITIVITY: 96.6% (93.29% ~ 98.84%)
-
SPECIFICITY: 100% (9, 97% 100%)
-
TOTAL AGREED: 9, 91% (97.63% ~ 99.60%) LOD: 96.86%
-
EN ISO 13485: 2016
-
ISO 18113-2: 2013
-
ISO 15223-1: 2016
-
ISO 23640: 2015
-
ISO 13641: 2002
-
ISO 14971: 2012
-
ISO 175511: 2003
-
20 TEST BOX
-
20 STERILE BUFFER
-
20 PRE-FILLED BUFFER SOLUTION TUBE
-
20 CAP FOR TUBE WITH DOSER
-
20 BAG FOR BIOLOGICAL WASTE